Dr. Catriona Jamieson is a co-founder and CEO of Aspera Biomedicines. She was a co-founder of Impact Biomedicines. Dr. Jamieson is a specialist in leukemia and myeloproliferative neoplasms. She is Deputy Director of the MooresCancer Center at UCSD, Director of the Sanford Stem Cell Clinical Center, and Professor of Medicine. She has a PhD in Microbiology/Immunology and an MD from the University of British Columbia. She trained in hematology, bone marrow transplantation and stem cell biology followed by being an attending hematologist at Stanford University prior to being recruited to UCSD.